0 seconds of 3 minutes, 45 secondsVolume 0%
Press shift question mark to access a list of keyboard shortcuts
00:00
03:45
03:45
 
  • Empower Clinics (CBDT) has provided an update on key initiatives of the company and its subsidiaries
  • Chairman & CEO Steven McAuley sat down with Folake Ekwubiri to highlight the updates
  • Empower is an integrated healthcare company that provides digital and telemedicine care
  • Empower Clinics Inc. (CBDT) opened trading at C$0.115 per share

Empower Clinics (CBDT) has provided an update on company and subsidiary initiatives.

Steven McAuley, Chairman and CEO of Empower Clinics sat down with Folake Ekwubiri to highlight the updates.

“The evolution of a growth company takes time and commitment…and passion matters. Healthcare is an important industry. It is a massive industry, and we are an important part of it.

We have a team of professionals who care about patients, health outcomes and the importance of our shareholders. That’s community…our collective…our journey together.”

Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, a medical device company and world-class medical diagnostics laboratories. Empower is aggressively growing its clinical and digital presence across North America.

Empower Clinics Inc. (CBDT) opened trading at C$0.115 per share.

 

More From The Market Online
AI generated stock image

@ the Bell: How did markets react to the Bank of Canada’s rate decision?

Canada’s main stock index climbed on Wednesday given the Bank of Canada policy decision while investors assessed shifting US tariff policies.
Patient and doctor wearing breast cancer ribbon

BriaCell therapy improves breast cancer survival rate

BriaCell stock (TSX:BCT) is positioned to the upside after posting positive survival data from its phase 2 breast cancer study.
AI generated stock image.

@ the Bell: Markets adjust to hint of tariff exemptions

Canada’s main stock index saw a slight uptick on Tuesday, driven by the White House’s indications of potential automotive tariff exemptions.
NurExone Biologic Inc

A promising investment in regenerative medicine

Biopharmaceutical company NurExone (TSXV:NRX) reached a significant milestone in its efforts to revolutionize spinal cord injury treatments.